Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

International Centre for Genetic Engineering and Biotechnology

Headquarters: Trieste, Italy
Year Founded: 1983
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Sep 8, 2022
Discovery & Translation

An inroad to bunyaviruses; plus a gene therapy for tyrosinemia and more

BioCentury’s roundup of translational news
BioCentury | Jun 4, 2022
Emerging Company Profile

Heqet: regenerating heart muscle cells via the Hippo pathway

King’s College spinout is inducing cardiomyocyte regeneration via nanoparticle-delivered miRNA
BioCentury | Apr 27, 2022
Deals

April 26 Quick Takes: CD24 will be new focus of Forty Seven founders as Stanford spinout Pheast debuts

Plus Nkarta follows breakthrough data with $200M raise, and updates from Epitopea, Forcefield and 
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cardiovascular

BioCentury | Oct 15, 2015
Distillery Techniques

Techniques: siRNAs that enhance gene therapy efficiency

BioCentury | Dec 20, 2012
Distillery Therapeutics

Indication: Cardiovascular disease

BioCentury | Dec 20, 2012
Distillery Therapeutics

Indication: Infectious disease

Items per page:
1 - 10 of 13
Help Center
Username
Request a Demo
Request Training
Ask a Question